AGP Executive Report
Last update: 10 hours agoCBD Wellness Research: A new study in eNeuro reports CBD may calm brain immune inflammation in an Alzheimer’s mouse model, pointing to neuroinflammation as a key target. Medical Access Expansion: Kentucky’s Speakeasy Dispensary is set to open in Bowling Green on June 5, aiming to close a regional access gap for registered patients. Regulatory Shock (Texas): Texas Delta-8 gummies and drinks are moving toward Schedule I treatment after a Supreme Court change took effect Thursday, leaving retailers and shoppers waiting on clearer state guidance. Market & Policy Watch: Lawmakers are urging the IRS/Treasury to issue “prompt” tax guidance for marijuana businesses after federal rescheduling shifts some cannabis to Schedule III, potentially changing how 280E applies. Product Safety: Missouri regulators issued a recall for certain THC vape cartridges after processing steps weren’t followed by the required post-processing THC concentrate testing. Industry Finance: Curaleaf announced a reverse stock split tied to potential uplisting requirements, signaling continued push for access to major U.S. exchanges. Enforcement & Supply Chains: Spain dismantled a drone-assisted drug network moving hashish and cocaine from Morocco into Spain, then onward to France.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
